AGORA HOLDINGS INC. Subsidiary, eSilkroad Network Limited, Enters into a Letter of Intent with the BEIJING NUOZHOU TECHNOLOGY COMPANY LTD. in Order to Pursue a Strategic Partnership
November 07, 2018 16:05 ET
|
Agora Holdings, Inc.
TORONTO, ON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Agora Holdings Inc. (OTC PINK: AGHI) (the “Company”) today announced that its 51% owned subsidiary, eSilkroad Network Limited, has...
Sunrun Reports Third Quarter 2018 Financial Results
November 07, 2018 16:05 ET
|
Sunrun Inc.
Total deployments of 100 MWs, an increase of 10% compared to the prior quarter Net Earning Assets increased $99 million and Cash increased $5 million during the quarter Reiterating full year...
Pfenex Reports Third Quarter Results and Provides Business Update
November 07, 2018 16:05 ET
|
Pfenex, Inc.
On track to submit the NDA for PF708 to the FDA in fourth quarter of 2018 SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) is a clinical-stage development and...
MediWound to Host Third Quarter 2018 Financial Results Conference Call on November 13 at 8:30 a.m. Eastern Time
November 07, 2018 16:05 ET
|
MediWound Ltd.
YAVNE, Israel, Nov. 07, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
Papa Murphy’s Holdings, Inc. Reports Third Quarter 2018 Results and Announces Financial and Strategic Alternatives Review
November 07, 2018 16:05 ET
|
Papa Murphy's Holdings, Inc.
Company Announces Extension of Credit Agreement VANCOUVER, Wash., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Papa Murphy’s Holdings, Inc. (the “Company”) (NASDAQ: FRSH) today announced results for its...
Opiant Pharmaceuticals, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update
November 07, 2018 16:05 ET
|
Opiant Pharmaceuticals, Inc.
SANTA MONICA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing pharmacological treatments for...
Axovant Announces Second Fiscal Quarter 2018 Financial Results and Corporate Updates
November 07, 2018 16:05 ET
|
Axovant Sciences Ltd.
First patient dosed in clinical study of AXO-Lenti-PD, a novel gene therapy for treatment of Parkinson’s diseaseExpanded pipeline of gene therapies with in-licensing of AXO-AAV-OPMD for treatment of...
UNITY Biotechnology, Inc. Reports Third Quarter 2018 Financial Results
November 07, 2018 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
Codexis to Present at Two Investment Conferences in November
November 07, 2018 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment...
Trupanion Announces Upcoming Investor Conference Participation
November 07, 2018 16:05 ET
|
Trupanion, Inc.
SEATTLE, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) announced today that members of Trupanion’s management team will participate in two upcoming investor conferences: Stifel...
- May 22, 2024 04:38 ET Global Coating Additives Market Trends and Forecasts 2024-2035: Strategic Partnerships are Driving Advancements, Asia Holds the Largest Share, Shift Towards Sustainability
- May 22, 2024 04:14 ET Configure Price Quote Software Global Strategic Analysis Report 2024: Market to Reach $7.3 Billion by 2030 - Rising Adoption of Automation Solutions in Business Operations